Parkinsonism in Spinocerebellar Ataxia

What is Spinocerebellar Ataxia?

Spinocerebellar ataxia (SCA) is a degenerative disease caused by atrophy to the cerebellum, the part of the brain responsible for coordination of movement. Clinical features of spinocerebellar ataxia include problems with speech, swallowing, balance and coordination, along with peripheral neuropathy, and muscle stiffness.

Non-cerebellar features can also be present with SCA, including REM (rapid eye movement) sleep behaviour disorder, daytime sleepiness, chorea, cognitive deficits, weight loss, and urinary dysfunction.

An increasing number of SCA subtypes have been associated with specific genes, and are categorised numerically, beginning SCA1, SCA2, SCA3, through to SCA36. The numbers do not indicate severity of symptoms or the disease, but instead the order in which the dominant genes associated with SCA were identified.

As SCA can present as parkinsonism, especially with subtypes SCA2, SCA3 and SCA17, testing for these subtypes of SCA may be beneficial in patients with Parkinson’s disease.

What is Parkinsonism?

Parkinsonism is a clinical syndrome presenting slowness of movement, stiffness, and tremors. Parkinsonism is a term covering a range of conditions with similar symptoms to Parkinson’s disease, which is the most common form of parkinsonism, the cause of which is still unknown. There are a number of causes of parkinsonism in other conditions, including side effects from medication and environmental toxins to aging and hereditary predisposition.

Parkinson
Parkinson's disease. 3D illustration showing neurons containing Lewy bodies small red spheres which are deposits of proteins accumulated in brain cells that cause their progressive degeneration. Image Credit: Kateryna Kon / Shuttertock

The clinical features of parkinsonism in spinocerebellar ataxia include:

  • Cerebellar ataxia
  • Dysarthria
  • Tremor
  • Hypoactive deep tendon reflexes
  • Peripheral neuropathy
  • Slow saccadic eye movement

One review has shown that after intention or postural upper-limb tremors,parkinsonism was the most common symptom concerning movement disorders at the onset of SCA.

SCA Subtypes and Parkinsonism

Parkinsonism is seen in various SCA subtypes. Levodopa-responsive Parkinson disease (PD) and atypical parkinsonism are particularly seen in SCA2, SCA3 and SCA17.

SCA2

SCA subtype SCA2 is the most commonly reported type of SCA associated with parkinsonism, and is fairly common in European populations. SCA2 has a low number of expansions and interrupted structures.

SCA3

SCA3 is common in western populations. In SCA3, atrophy of the following areas has been observed:

  • Pons
  • Basal ganglia
  • Midbrain
  • Medulla oblongata
  • Multiple cranial nerve nuclei
  • Thalamus
  • Frontal, parietal, temporal, occipital and limbic lobes

Degeneration of the substantia nigra (a basal ganglia structure) has also been observed.

SCA6 and SCA8

Spinocerebellar ataxia subtypes SCA6 and SCA8 may present parkinsonism, but SCA6 more is more commonly seen in the form of pure ataxia. Laboratory evaluations of a 69-year-old woman with gait ataxia showed that parkinsonism associated with SCA6 is pathologically similar to idiopathic Parkinson’s disease.

SCA17

Parkinsonism in SCA17 is more commonly seen in Asian populations, and especially in Korea.

Alternative Risk Factors

While many people will have DNA repetitions seen in patients with spinocerebellar ataxia, this does not guarantee the onset of the disease at any point in life. However, those with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease characterized by gradual difficulties with grip, alterations in vocal pitch, fatigue, and muscle cramps and twitches, with SCA2, has been reported to pose a higher risk of parkinsonism. SCA can also involve other nervous systems and lead to various neurodegenerative diseases, and is not solely limited to the cerebellar system.

Summary

Parkinsonism is the most commonly reported symptom of spinocerebellar ataxia, and so patients who solely present parkinsonism, should also have SCA considered as a possible diagnosis. Further pathological research is necessary to fully understand why spinocerebellar ataxia can sometimes present as parkinsonism. Additionally, the geographical differences in prevalence of parkinsonism and SCA needs to be investigated further to better understand global differences in incidence and prevalence, and to form solid conclusions on the epidemiology of SCA worldwide.

Further Reading

Last Updated: Sep 24, 2022

Lois Zoppi

Written by

Lois Zoppi

Lois is a freelance copywriter based in the UK. She graduated from the University of Sussex with a BA in Media Practice, having specialized in screenwriting. She maintains a focus on anxiety disorders and depression and aims to explore other areas of mental health including dissociative disorders such as maladaptive daydreaming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zoppi, Lois. (2022, September 24). Parkinsonism in Spinocerebellar Ataxia. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/health/Parkinsonism-in-Spinocerebellar-Ataxia.aspx.

  • MLA

    Zoppi, Lois. "Parkinsonism in Spinocerebellar Ataxia". News-Medical. 21 December 2024. <https://www.news-medical.net/health/Parkinsonism-in-Spinocerebellar-Ataxia.aspx>.

  • Chicago

    Zoppi, Lois. "Parkinsonism in Spinocerebellar Ataxia". News-Medical. https://www.news-medical.net/health/Parkinsonism-in-Spinocerebellar-Ataxia.aspx. (accessed December 21, 2024).

  • Harvard

    Zoppi, Lois. 2022. Parkinsonism in Spinocerebellar Ataxia. News-Medical, viewed 21 December 2024, https://www.news-medical.net/health/Parkinsonism-in-Spinocerebellar-Ataxia.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein target offers promise for alleviating cognitive decline in Parkinson's disease